In this issue:
- Chocolate and type 2 diabetes risk
- Factors associated with weight loss response with GLP-1 agonists
- Type 2 diabetes in women with GDM vs. impaired glucose tolerance
- Oral glucose-lowering agents vs. insulin for GDM
- Projected increase in NZ diabetes prevalence
- Association of HDL with major adverse CV events/ mortality in type 2 diabetes
- Diabetes overtreatment and hypoglycaemia in older type 2 diabetics on insulin
- Postprandial hypoglycaemia after gastric bypass in type 2 diabetes
- Effects of GLP-1 agonists on renal and CV outcomes
- Hybrid closed-loop therapy and severe hypoglycaemia/DKA risk in type 1 diabetes
Please login below to download this issue (PDF)